|제목||Professor Hwang Byunghee’s New Research Result proves Partial Peptide Promotes Hemostasis.|
|simple||Professor Byunghee Hwang’s (INU Division of Bioengineering) research team’s research result on Human Neutrophil Peptide got issued in ‘Biotechnology Journal’. The research result will be protected under intellectual property rights, by applying patent.|
Professor Byunghee Hwang’s (INU Division of Bioengineering) research team’s research result on Human Neutrophil Peptide got issued in ‘Biotechnology Journal’. The research result will be protected under intellectual property rights, by applying patent.
Professor Hwang’s team found that a partial peptide (HNP-F) promotes hemostasis by blood coagulation ability test. This HNP-F showed the best hemostatic effect between anterior half and posterior half peptides. It also could be easily converged with other proteins within its easy chemical synthesis.
This hemostasis peptide is identified through mouse liver experiment. Blood loss of the mouse was measured by injecting liquefied hemostasis peptide. The experiment demonstrated that the hemostasis effect was as influential as polymer hemostasis materials, such as keto acid.
This HNP-F could be mass-produced, and its biosafety is guaranteed. As the peptide is human-oriented hemostasis, the peptide would not cause immune or allergic reaction. The peptide could be stored for a long time, with a very low virus infect possibility.
HNP-F is expected to be developed as a new styptic or hemostasis supplement considering the advantages that HNP-F carries.
The research was supported by Ministry of Maritime Affairs and Fisheries’ ‘Marine Complex Fiber Material and Bioplastic material technology development’ project. The name of the article is: Newly Identified Partial Peptide Promoting Hemostasis Originated from Human Neutrophil Peptide 1.
지역의 인재를 창의적인 세계의 인재로 키우는 대학!